Page last updated: 2024-10-16

quinacrine and Acute Hypercapnic Respiratory Failure

quinacrine has been researched along with Acute Hypercapnic Respiratory Failure in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takita, K1
Herlenius, E1
Yamamoto, Y1
Lindahl, SG1
Kattwinkel, J1
Taussig, LM1
McIntosh, CL1
di Sant'Agnese, PA1
Wood, RE1

Other Studies

2 other studies available for quinacrine and Acute Hypercapnic Respiratory Failure

ArticleYear
Effects of neuroactive substances on the morphine-induced respiratory depression; an in vitro study.
    Brain research, 2000, Nov-24, Volume: 884, Issue:1--2

    Topics: Acetylcholine; Animals; Animals, Newborn; Colforsin; Drug Interactions; Efferent Pathways; Haloperid

2000
Intrapleural instillation of quinacrine for recurrent pneumothorax. Use in a patient with cystic fibrosis.
    JAMA, 1973, Oct-29, Volume: 226, Issue:5

    Topics: Adult; Autopsy; Cystic Fibrosis; Follow-Up Studies; Humans; Male; Methods; Pleura; Pleural Diseases;

1973